- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00323219
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
Study Overview
Detailed Description
Extended description of the protocol, including information not already contained in other fields.
Objective: To compare 400 mg of oral moxifloxacin (Oral Group) once daily to 2 grams of IV cefazolin and 1 gram of oral probenecid once daily (IV group) for the treatment of moderate cellulitis.
Patients: Any patient presenting to the emergency department at St Paul's Hospital in Vancouver with a diagnosis of cellulitis requiring IV antibiotics, without contraindications to any of the study treatments, and not requiring hospital admission.
Assessments: Daily assessments are performed double-blind at 0, 1, 2, 3, 4, 5, 6, 7 and 14 days.
Primary outcome: Clinical cure at 7 days (resolution of symptoms, no change in antibiotic, no adverse events requiring discontinuation of study drug, no admission to hospital).
Secondary outcomes: Area of erythema, days of treatment, side-effects of medication, cost of treatment, patient satisfaction, relapse at 14 days.
Sample size: Based on equivalence of treatments a total of 390 patients are required (195/group).
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Barb Boychuk
- Email: robstenstrom@shaw.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V1Y 1Z1
- Recruiting
- St. Paul's Hospital, Providence Healthcare, Emergency Medicine
-
Contact:
- Barb Boychuk
-
Principal Investigator:
- Rob Stenstrom, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Cellulitis requiring outpatient intravenous antibiotic therapy;
- ability to understand,/sign informed consent;
- no contraindications to study medications,
- not pregnant/breastfeeding
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Clinical cure at 7 days
Time Frame: 7 days
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Area of erythema (Days 0, 1, 2, 3, 4, 5, 6, 7), days of treatment, side-effects of medication, cost of treatment, patient satisfaction, relapse at 14 days
Time Frame: 7 days
|
7 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rob Stenstrom, MD, The University of British Columbia
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Inflammation
- Disease Attributes
- Connective Tissue Diseases
- Skin Diseases, Infectious
- Suppuration
- Emergencies
- Cellulitis
- Soft Tissue Infections
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Antineoplastic Agents
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
- Anti-Bacterial Agents
- Moxifloxacin
- Cefazolin
Other Study ID Numbers
- PO3-0153
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cellulitis
-
McGill University Health Centre/Research Institute...CompletedCellulitis | Cellulitis of Leg | Cellulitis of ArmCanada
-
University of SouthamptonUniversity of Nottingham; Norfolk and Norwich University Hospitals NHS Foundation... and other collaboratorsNot yet recruitingCellulitis of Leg
-
Hillel Yaffe Medical CenterUnknown
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedUncomplicated Outpatient CellulitisCanada
-
University of SussexCompletedCellulitis | Cellulitis of Leg | Antibiotic DurationUnited Kingdom
-
University Hospital Plymouth NHS TrustTerminated
-
InMode MD Ltd.RecruitingCellulitis of LegUnited States
-
BTL Industries Ltd.CompletedCellulitis | Cellulite | Cellulitis of LegUnited States
-
Cairo UniversityRecruitingFibrosis | Lower Limb Lymphedema | Cellulitis of LegEgypt
-
Indústria Brasileira Equipamentos Médicos - IBRAMEDUnknown
Clinical Trials on Cefazolin and Moxifloxacin
-
B. Braun Medical Inc.ParexelCompleted
-
Abdul El-RabbanyNot yet recruitingOrthognathic Surgical Site Infection
-
University of Missouri-ColumbiaCompletedWounds and Injuries | Fractures, ClosedUnited States
-
B. Braun Medical Inc.Terminated
-
Aultman Health FoundationCompletedWound InfectionUnited States
-
Phillip Brian SmithEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSepsis | PrematurityBrazil
-
Stanford UniversityCompletedPre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery PatientsAortic Valve Disorder | Congenital Heart DiseasesUnited States
-
University of Campinas, BrazilRecruitingEndophthalmitis | Moxifloxacin | Open Globe Injury | Post-Traumatic EndophthalmitisBrazil
-
Brigham and Women's HospitalCompletedAntibiotic ProphylaxisUnited States